解析ω-3 脂肪酸的脂类介质的抗炎作用及其在 SARS-CoV-2 中的意义。
Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.
机构信息
Exeltis Healthcare, Adalperostr. 84, 85737 Ismaning, Germany.
Solutex SA, Avenida de la Transición Espanola 24, 28108 Alcobendas, Spain.
出版信息
Med Hypotheses. 2020 Dec;145:110340. doi: 10.1016/j.mehy.2020.110340. Epub 2020 Oct 8.
COVID-19 is a new disease caused by coronavirus SARS-CoV-2. It was first described in 2019, developed into an epidemic in January 2020 and has spread the global to the present COVID-19 pandemic. Specialized pro‑resolving mediators (SPMs) may play a new role in the management of this lung disease because SPM actively stimulate the resolution of infectious inflammation and are organ protective in animal disease models. Many tissues have been suitable targets for treating inflammation with SPMs or their active precursors 18-HEPE, 17-HDHA and the 14-HDHA, in order to elicit dynamic resolution of inflammation. Here we discuss the possible mode of action of these substances in the management of SARS Covid 19.
新型冠状病毒肺炎（Corona Virus Disease 2019，COVID-19）由冠状病毒 SARS-CoV-2 引起，于 2019 年首次被描述，2020 年 1 月发展为流行疫情，目前已蔓延至全球 COVID-19 大流行。特殊的促分解介质（Specialized pro-resolving mediators，SPM）可能在这种肺部疾病的治疗中发挥新作用，因为 SPM 可积极刺激传染性炎症的消退，并在动物疾病模型中具有器官保护作用。为了引发炎症的动态消退，许多组织已成为用 SPM 或其活性前体 18-HEPE、17-HDHA 和 14-HDHA 治疗炎症的合适靶点。在这里，我们讨论了这些物质在 SARS-CoV-2 管理中的可能作用模式。
Zotero 插件